To attain fully functional biological activity, vitamin-K dependent coagulation factors (VKDCF) are γ-carboxylated prior to secretion from liver. Warfarin impairs the γ-carboxylation, and consequently their physiological function. Bothrops jararaca snake venom (BjV) contains several activators of blood coagulation, especially procoagulant enzymes (prothrombin and factor X activators) and thrombin-like enzymes. In order to clarify the relative contribution of prothrombin and factor X activators to the hemostatic disturbances occurring during experimental B. jararaca envenomation, warfarin was used to deplete VKDCF, prior to BjV administration. Male Wistar rats were pretreated with saline (Sal) or warfarin (War) and inoculated subsequently with BjV or saline, thus forming four groups: Sal + Sal (negative control), Sal + BjV (positive control), War + Sal (warfarinization control), and War + BjV. Three hours after inoculation, prothrombin and factor X levels fell 40% and 50%, respectively; levels of both factors decreased more than 97% in the War + Sal and War + BjV groups. Platelet counts dropped 93% and 76% in Sal + BjV and War + BjV, respectively, and plasma fibrinogen levels decreased 86% exclusively in Sal + BjV. After 6 and 24 h, platelet counts and fibrinogen levels increased progressively. A dramatic augmentation in plasma hemoglobin levels and the presence of schizocytes and microcytes in the Sal + BjV group indicated the development of intravascular hemolysis, which was prevented by warfarin pretreatment. Our findings show that intravascular thrombin generation has the foremost role in the pathogenesis of coagulopathy and intravascular hemolysis, but not in the development of thrombocytopenia, in B. jararaca envenomation in rats; in addition, fibrinogenases (metalloproteinases) may contribute to coagulopathy more than thrombin-like enzymes.
KamigutiASMatsunagaSSpirMSano-MartinsISNahasL. Alterations of the blood coagulation system after accidental human inoculation by Bothrops jararaca venom. Braz J Med Biol Res1986; 19: 199–204.
2.
MaruyamaMKamigutiASCardosoJLCSano-MartinsISChudzinskiAMSantoroMLMorenaPTomySCAntonioLCMiharaHKelenEMA. Studies on blood coagulation and fibrinolysis in patients bitten by Bothrops jararaca (jararaca). Thromb Haemost1990; 63: 449–53.
3.
SantoroMLSano-MartinsISFanHWCardosoJLCTheakstonRDGWarrellDABIASG. Haematological evaluation of patients bitten by the jararaca, Bothrops jararaca, in Brazil. Toxicon2008; 51: 1440–8.
4.
CardosoJLCFanHWFrançaFOSJorgeMTLeiteRPNishiokaSAAvilaASano-MartinsISTomySCSantoroMLChudzinskiAMCastroSCBKamigutiASKelenEMAHirataMHMirandolaRMSTheakstonRDGWarrellDA. Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in São Paulo, Brazil. Q J Med1993; 86: 315–25.
5.
SajevicTLeonardiAKrizajI. Haemostatically active proteins in snake venoms. Toxicon2011; 57: 627–45.
HofmannHBonC. Blood coagulation induced by the venom of Bothrops atrox. 1. Identification, purification, and properties of a prothrombin activator. Biochemistry1987; 26: 772–80.
8.
MaruyamaMKamigutiASTomySCAntonioLCSugikiMMiharaH. Prothrombin and factor X activating properties of Bothrops erythromelas venom. Ann Trop Med Parasitol1992; 86: 549–56.
9.
GeradsIGovers-RiemslagJWPTansGZwaalRFARosingJ. Prothrombin activation on membraness with anionic lipids containing phosphate, sulfate, and/or carboxyl groups. Biochemistry1990; 29: 7967–74.
10.
BergerMPintoAFGuimarãesJA. Purification and functional characterization of bothrojaractivase, a prothrombin-activating metalloproteinase isolated from Bothrops jararaca snake venom. Toxicon2008; 51: 488–501.
11.
SenisYAKimPYFullerGLGarciaAPrabhakarSWilkinsonMCBrittanHZitzmannNWaitRWarrellDAWatsonSPKamigutiASTheakstonRDNesheimMELaingGD. Isolation and characterization of cotiaractivase, a novel low molecular weight prothrombin activator from the venom of Bothrops cotiara. Biochim Biophys Acta2006; 1764: 863–71.
12.
KitanoESGarciaTCMenezesMCTashimaAKZelanisASerranoSM. Cotiarinase is a novel prothrombin activator from the venom of Bothrops cotiara. Biochimie2013; 95: 1655–9.
13.
ModestoJCJunqueira-de-AzevedoILNeves-FerreiraAGFritzenMOlivaMLHoPLPeralesJChudzinski-TavassiAM. Insularinase A, a prothrombin activator from Bothrops insularis venom, is a metalloprotease derived from a gene encoding protease and disintegrin domains. Biol Chem2005; 386: 589–600.
14.
LoríaGDRucavadoAKamigutiASTheakstonRDFoxJWAlapeAGutiérrezJM. Characterization of ‘basparin A,' a prothrombin-activating metalloproteinase, from the venom of the snake Bothrops asper that inhibits platelet aggregation and induces defibrination and thrombosis. Arch Biochem Biophys2003; 418: 13–24.
15.
SilvaMBSchattnerMRamosCRJunqueira-de-AzevedoILGuarnieriMCLazzariMASampaioCAPoznerRGVenturaJSHoPLChudzinski-TavassiAM. A prothrombin activator from Bothrops erythromelas (jararaca-da-seca) snake venom: characterization and molecular cloning. Biochem J2003; 369: 129–39.
16.
HofmannHBonC. Blood coagulation induced by the venom of Bothrops atrox. 2. Identification, purification, and properties of two factor X activators. Biochemistry1987; 26: 780–7.
17.
Morais-ZaniKMoraesFCSilvaJBTorquatoRJSTanakaASTanaka-AzevedoAM. Isolation and characterization of a novel factor X activator enzyme from the venom of Bothrops jararaca. J Biosci Med2012; 2: 1–7.
18.
CastroHCZingaliRBAlbuquerqueMGPujol-LuzMRodriguesCR. Snake venom thrombin-like enzymes: from reptilase to now. Cell Mol Life Sci2004; 61: 843–56.
Paes LemeAFPrezotoBCYamashiroETBertholimLTashimaAKKlitzkeCFCamargoACSerranoSM. Bothrops protease A, a unique highly glycosylated serine proteinase, is a potent, specific fibrinogenolytic agent. J Thromb Haemost2008; 6: 1363–72.
21.
MoraisNCNeves MamedeCCFonsecaKCde QueirozMRGomes-FilhoSASantos-FilhoNABordon KdeCBelettiMESampaioSVArantesECde OliveiraF. Isolation and characterization of moojenin, an acid-active, anticoagulant metalloproteinase from Bothrops moojeni venom. Toxicon2012; 60: 1251–8.
22.
SilvaIRLorenzettiRRennóALBaldisseraLJrZelanisASerranoSMHyslopS. BJ-PI2, a non-hemorrhagic metalloproteinase from Bothrops jararaca snake venom. Biochim Biophys Acta2012; 1820: 1809–21.
23.
StockerKFischerHMeierJBrogliMSvendsenL. Protein C activators in snake venoms. Behring Inst Mitteilungen1986; 79: 37–47.
24.
ZingaliRBJandrot-PerrusMGuillinMCBonC. Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: characterization and mechanism of thrombin inhibition. Biochemistry1993; 32: 10794–802.
25.
CastroHCDutraDLSOliveira-CarvalhoALZingaliRB. Bothroalternin, a thrombin inhibitor from the venom of Bothrops alternatus. Toxicon1998; 36: 1903–12.
26.
SekiyaFAtodaHMoritaT. Isolation and characterization of an anticoagulant protein homologous to botrocetin from the venom of Bothrops jararaca. Biochemistry1993; 32: 6892–7.
27.
YamashitaKMAlvesAFBarbaroKCSantoroML. Bothrops jararaca venom metalloproteinases are essential for coagulopathy and increase plasma tissue factor levels during envenomation. PLoS Negl Trop Dis2014; 8: e2814–e2814.
28.
FerlandG. The discovery of vitamin K and its clinical applications. Ann Nutr Metab2012; 61: 213–8.
29.
ElgMGustafssonDCarlssonS. Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat. Thromb Res1999; 94: 187–97.
30.
JossoFLavergneJMGouaultMProu-WartelleOSoulierJP. Différents états moléculaires du facter II (prothrombine). Leur étude à l'aide de la staphylocoagulase et d'anticorps anti-facteur II. I. Le facteur II chez les sujets traites par les antagonistes de la vitamine K. Thromb Diath Haemorrh1968; 20: 88–98.
31.
NelsestuenGLSuttieJW. The purification and properties of an abnormal prothrombin protein produced by dicumarol-treated cows. A comparison to normal prothrombin. J Biol Chem1972; 247: 8176–82.
32.
StenfloJGanrotPO. Vitamin K and the biosynthesis of prothrombin. I. Identification and purification of a dicoumarol-induced abnormal prothrombin from bovine plasma. J Biol Chem1972; 247: 8160–6.
33.
SuttieJW. Mechanism of action of vitamin K: demonstration of a liver precursor of prothrombin. Science1973; 179: 192–4.
34.
CarlisleTLShahDVSchlegelRSuttieJW. Plasma abnormal prothrombin and microsomal prothrombin percursor in various species. Proc Soc Exp Biol Med1975; 148: 140–4.
35.
MorrisseyJJJonesJPOlsonRE. Isolation and characterization of isoprothrombin in the rat. Biochem Biophys Res Commun1973; 54: 1075–82.
36.
ShahDVSwansonJCSuttieJW. Abnormal prothrombin in the vitamin K-deficient rat. Thromb Res1984; 35: 451–8.
37.
StantonCWallinR. Processing and trafficking of clotting factor X in the secretory pathway. Effects of warfarin. Biochem J1992; 284: 25–31.
38.
HarauchiTTakanoKMatsuuraMYoshizakiT. Liver and plasma levels of descarboxyprothrombin (PIVKA II) in vitamin K deficiency in rats. Jpn J Pharmacol1986; 40: 491–9.
39.
KurataMIidakaTYamasakiNSasayamaYHamadaY. Battery of tests for profiling abnormalities of vitamin K-dependent coagulation factors in drug-toxicity studies in rats. Exp Anim2005; 54: 189–92.
40.
CorriganJJJr.EarnestDL. Factor II antigen in liver disease and warfarin-induced vitamin K deficiency: correlation with coagulant activity using Echis venom. Am J Hematol1980; 8: 249–55.
41.
HashimotoNMoritaTIwanagaS. A method for systematic purification from bovine plasma of six vitamin K-dependent coagulation factors: prothrombin, factor X, factor IX, protein S, protein C, and protein Z. J Biochem (Tokyo)1985; 97: 1347–55.
42.
LaffanMAManningRInvestigation of haemostasis. In: BainBJBatesILaffanMALewisSM (eds). Dacie and Lewis practical haematology, 11th ed. China: Churchill Livingstone, 2012, pp. 393–446.
43.
AntunesTCYamashitaKMBarbaroKCSaikiMSantoroML. Comparative analysis of newborn and adult Bothrops jararaca snake venoms. Toxicon2010; 56: 1443–58.
44.
Miller JN, Miller JC. Calibration methods in instrumental analysis: regression and correlation. Statistics and chemometrics for analytical chemistry. 6th ed. Prentice Hall, 2010, pp.110–53.
45.
SantoroMLSano-MartinsISChamoneDAF. In vivo platelet activation induced by Bothrops jararaca venom in rabbits. Platelets1994; 5: 162–70.
46.
RatnoffODMenzieC. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med1951; 37: 216–320.
47.
StandeferJCVanderjagtD. Use of tetramethylbenzidine in plasma hemoglobin assay. Clin Chem1977; 23: 749–51.
48.
BlancoANKordichLCMartinez CanavieriADeterminación del factor II. In: KordichLCAvalosJCSVidalHOGuerraCC (eds). Manual de hemostasia y trombosis, 2nd ed. Buenos Aires: Grupo CLAHT, 1990, pp. 255–7.
49.
DensonKWBorrettRBiggsR. The specific assay of prothrombin using the Taipan snake venom. Br J Haematol1971; 21: 219–26.
50.
BlancoANMartinez CanavieriADeterminación del factor X. In: KordichLCAvalosJCSVidalHOGuerraCC (eds). Manual de hemostasia y trombosis, 2nd ed. Buenos Aires: Grupo CLAHT, 1990, pp. 266–7.
51.
BelijSMiljkovićDPopovASubotaVTimotijevićGSlavićMMirkovIKataranovskiDKataranovskiM. Effects of subacute oral warfarin administration on peripheral blood granulocytes in rats. Food Chem Toxicol2012; 50: 1499–507.
52.
RosenfeldGNahasLKelenEMACoagulant proteolytic, and hemolytic properties of some snake venoms. In: BücherlWBuckleyEDeulofeuV (eds). Venomous animals and their venoms1968; Vol 1. 1st ed. New York, NY: Academic Press Inc., pp. 229–273.
53.
AronsonDLEffect of Russell's viper venom infusion on coagulation in the rabbit: cascade to trickle. In: PirkleHMarklandFS (eds). Hemostasis and animal venoms, New York, NY: Marcel Dekker, 1988, pp. 481–90.
54.
ClemensRPukrittayakameeSVanijanontaSNontprasertABockHLCharoenlarpPWhiteNJ. Therapeutic effects of antivenom supplemented by antithrombin III in rats experimentally envenomated with Russell's viper (Daboia russelli siamensis) venom. Toxicon1995; 33: 77–82.
55.
RapaportSIToneffTRimonAWarn-CramerBJ. The effect of immunodepletion of antithrombin III on the response of rabbits to Russell's viper venom-induced activation of factor X. Arterioscler Thromb Vasc Biol1997; 17: 409–16.
56.
Málaque CMS, Crespo FG, Novaes CTG, Fan HW, Medeiros CR, França FOS, Cardoso JLC, Prado JCL, Risk JY. Intravascular hemolysis in human Bothrops envenomation: more than we supposed. In: VIII Reunião Científica Anual do Instituto Butantan, v63, São Paulo, Brazil, 6–8 December 2006, p.13.
57.
BaroneJMAlpontiRFFrezzattiRZambotti-VillelaLSilveiraPF. Differential efficiency of simvastatin and lipoic acid treatments on Bothrops jararaca envenomation-induced acute kidney injury in mice. Toxicon2011; 57: 148–56.
58.
RezendeNAAmaralCFSBambirraEALachattJJCoimbraTM. Functional and histopathological renal changes induced in rats by Bothrops jararaca venom. Braz J Med Biol Res1989; 22: 407–16.
59.
BurdmannEAWoronikVPradoEBAAbdulkaderRCSaldanhaLBBarretoOCOMarcondesM. Snakebite-induced acute renal failure: an experimental model. Am J Trop Med Hyg1993; 48: 82–8.
60.
Novaes CTG, Málaque CMS, Fan HW, Crespo FG, Medeiros CR, França FOS, Cardoso JLC, Prado JCL, Risk JY. Risk factors associated with acute renal failure in patients bitten by Bothrops snake, v. 63. In: VIII Reunião Científica Anual do Instituto Butantan, São Paulo, Brazil, 6–8 December 2006, p.12.
61.
SchneemannMCathomasRLaidlawSTEl NahasAMTheakstonRDWarrellDA. Life-threatening envenoming by the Saharan horned viper (Cerastes cerastes) causing micro-angiopathic haemolysis, coagulopathy and acute renal failure: clinical cases and review. Q J Med2004; 97: 717–27.
62.
SuntravatMYusuksawadMSereemaspunAPerezJCNuchprayoonI. Effect of purified Russell's viper venom-factor X activator (RVV-X) on renal hemodynamics, renal functions, and coagulopathy in rats. Toxicon2011; 58: 230–8.
63.
RosenfeldGKelenEMANudelF. Hemolytic activity of animal venoms. I. Classification in different types and activities. Mem Inst Butantan1960–62; 30: 117–32.
64.
RosenfeldGSymptomatology, pathology, and treatment of snake bites in South America. In: BücherlWBuckeleyEE (eds). Venomous animals and their venoms1971; Vol 2, New York, NY: Academic Press, pp. 345–84.
